Lupus myocarditis: Initial presentation and longterm outcomes in a multicentric series of 29 patients

Journal of Rheumatology

Volumn 44, Issue 1, 2017, Pages 24-32

  Thomas, Guillemette ^a,b   Aubart, Fleur Cohen ^a   Chiche, Laurent ^b   Haroche, Julien ^a   Hie, Miguel ^a   Hervier, Baptiste ^a   Costedoat Chalumeau, Nathalie ^c   Mazodier, Karine ^d   Ebbo, Mikael ^d   Cluzel, Philippe ^e   Cordel, Nadege ^f   Ribes, David ^g   Chastre, Jean ^h   Schleinitz, Nicolas ⁱ   Veit, Veronique ⁱ   Piette, Jean Charles ^j   Harle, Jean Robert ⁱ   Combes, Alain ^a,h   Amoura, Zahir ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b Européen Hospital   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL DE LA CONCEPTION   (France)

^e ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^f Centre Hospitalier Universitaire Pointe a Pitre   (Guadeloupe)

^g TOULOUSE UNIVERSITY HOSPITAL   (France)

^h INSERM   (France)

ⁱ TIMONE HOSPITAL   (France)

^j Centre National de Référence pour les Maladies Systémiques Rares   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; DOBUTAMINE; EPINEPHRINE; GADOLINIUM; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHOTREXATE; METHYLPREDNISOLONE; MYCOPHENOLATE MOFETIL; NORADRENALIN; PREDNISONE; TROPONIN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID;

ADOLESCENT; ADULT; ARTERY CATHETERIZATION; ARTICLE; BIOPSY TECHNIQUE; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR MORTALITY; CLINICAL ARTICLE; CLINICAL FEATURE; CORONARY ANGIOGRAPHY; DRUG MEGADOSE; DRUG PULSE THERAPY; ECHOCARDIOGRAPHY; ELECTROCARDIOGRAPHY; EXTRACORPOREAL OXYGENATION; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; HUMAN TISSUE; IMAGE ENHANCEMENT; MALE; MULTICENTER STUDY; MYOCARDITIS; OUTCOME ASSESSMENT; PERICARDIAL EFFUSION; PLASMA EXCHANGE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RADIOLOGICAL PARAMETERS; RETROSPECTIVE STUDY; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT DURATION; TREATMENT RESPONSE; CLINICAL TRIAL; COMPLICATION; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; SYMPTOM ASSESSMENT; TREATMENT OUTCOME; YOUNG ADULT;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; CYCLOPHOSPHAMIDE; ECHOCARDIOGRAPHY; FEMALE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; MYOCARDITIS; RETROSPECTIVE STUDIES; SYMPTOM ASSESSMENT; TREATMENT OUTCOME; YOUNG ADULT;

EID: 85008186405     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.160493     Document Type: Article

References (34)

1. Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri M. Cardiac involvement in systemic lupus erythematosus. Lupus 2005;14:683-6.
2. Doherty NE, Siegel RJ. Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1985;110:1257-65.
3. Griffith GC, Vural IL. Acute and subacute disseminated lupus erythematosus; a correlation of clinical and postmortem findings in eighteen cases. Circulation 1951;3:492-500.
4. Hejtmancik MR, Wright JC, Quint R, Jennings FL. The cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 1964;68:119-30.
5. Wijetunga M, Rockson S. Myocarditis in systemic lupus erythematosus. Am J Med 2002;113:419-23.
6. Zawadowski GM, Klarich KW, Moder KG, Edwards WD, Cooper LT Jr. A contemporary case series of lupus myocarditis. Lupus 2012;21:1378-84.
7. Ishimori ML, Agarwal M, Beigel R, Ng RK, Firooz N, Weisman MH, et al. Systemic lupus erythematosus cardiomyopathy- a case series demonstrating a reversible form of left ventricular dysfunction. Echocardiography 2014;31:563-8.
8. Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, et al. The role of endomyocardial biopsy in the management of cardiovascular disease: A scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Endorsed by the Heart Failure Society of America and the Heart Failure Association of the European Society of Cardiology. J Am Coll Cardiol 2007;50:1914-31.
9. Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: A position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013;34:2636-48, 48a-48d.
10. Cooper LT Jr. Myocarditis. N Engl J Med 2009;360:1526-38.
11. Mavrogeni S, Bratis C, Iakovou I, Kolovou G. Systemic lupus erythematosus: Two sides of the same coin evaluated by cardiovascular magnetic resonance imaging. Lupus 2011;20:1338-9.
12. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
13. Garcia MA, Alarcon GS, Boggio G, Hachuel L, Marcos AI, Marcos JC, et al. Primary cardiac disease in systemic lupus erythematosus patients: Protective and risk factors-data from a multi-ethnic Latin American cohort. Rheumatology 2014;53:1431-8.
14. Chung JW, Joe DY, Park HJ, Kim HA, Park HS, Suh CH. Clinical characteristics of lupus myocarditis in Korea. Rheumatol Int 2008;28:275-80.
15. Law WG, Thong BY, Lian TY, Kong KO, Chng HH. Acute lupus myocarditis: Clinical features and outcome of an oriental case series. Lupus 2005;14:827-31.
16. Dorner T. Therapy: Hydroxychloroquine in SLE: Old drug, new perspectives. Nat Rev Rheumatol 2010;6:10-1.
17. Sawalha AH, Harley JB. Antinuclear autoantibodies in systemic lupus erythematosus. Curr Op Rheumatol 2004;16:534-40.
18. Appenzeller S, Pineau CA, Clarke AE. Acute lupus myocarditis: Clinical features and outcome. Lupus 2011;20:981-8.
19. Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with myocarditis. Experimental and clinical correlates. Circulation 1997;91:163-8.
20. Kindermann I, Barth C, Mahfoud F, Ukena C, Lenski M, Yilmaz A, et al. Update on myocarditis. J Am Coll Cardiol 2012;59:779-92.
21. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, Fenoglio JJ Jr., et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987;1:3-14.
22. From AM, Maleszewski JJ, Rihal CS. Current status of endomyocardial biopsy. Mayo Clinic Proc 2011;86:1095-102.
23. Yilmaz A, Kindermann I, Kindermann M, Mahfoud F, Ukena C, Athanasiadis A, et al. Comparative evaluation of left and right ventricular endomyocardial biopsy: Differences in complication rate and diagnostic performance. Circulation 2010;122:900-9.
24. Mahrholdt H, Goedecke C, Wagner A, Meinhardt G, Athanasiadis A, Vogelsberg H, et al. Cardiovascular magnetic resonance assessment of human myocarditis: A comparison to histology and molecular pathology. Circulation 2004;109:1250-8.
25. Friedrich MG, Sechtem U, Schulz-Menger J, Holmvang G, Alakija P, Cooper LT, et al. Cardiovascular magnetic resonance in myocarditis: A JACC White Paper. J Am Coll Cardiol 2009;53:1475-87.
26. Mavrogeni S, Dimitroulas T, Kitas GD. Multimodality imaging and the emerging role of cardiac magnetic resonance in autoimmune myocarditis. Autoimmunity Rev 2012;12:305-12.
27. Mavrogeni S, Bratis K, Markussis V, Spargias C, Papadopoulou E, Papamentzelopoulos S, et al. The diagnostic role of cardiac magnetic resonance imaging in detecting myocardial inflammation in systemic lupus erythematosus. Differentiation from viral myocarditis. Lupus 2013;22:34-43.
28. Micheloud D, Calderon M, Caparrros M, D'Cruz DP. Intravenous immunoglobulin therapy in severe lupus myocarditis: Good outcome in three patients. Ann Rheum Dis 2007;66:986-7.
29. Suri V, Varma S, Joshi K, Malhotra P, Kumari S, Jain S. Lupus myocarditis: Marked improvement in cardiac function after intravenous immunoglobulin therapy. Rheumatol Int 2010; 30:1503-5.
30. Barnado A, Kamen DL. Myocarditis successfully treated with intravenous immunoglobulin in a patient with systemic lupus erythematosus and myositis. Am J Med Sci 2014;347:256-7.
31. Aggarwal P, Singh S, Suri D, Rawat A, Narula N, ManojKumar R. Rituximab in childhood lupus myocarditis. Rheumatol Int 2012;32:1843-4.
32. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, et al. 2009 focused update: ACCF/AHA Guidelines for the Diagnosis and Management of Heart Failure in Adults: A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: Developed in collaboration with the International Society for Heart and Lung Transplantation. Circulation 2009;119:1977-2016.
33. Mirabel M, Luyt CE, Leprince P, Trouillet JL, Leger P, Pavie A, et al. Outcomes, long-term quality of life, and psychologic assessment of fulminant myocarditis patients rescued by mechanical circulatory support. Crit Care Med 2011;39:1029-35.
34. Li X, Ren H, Zhang Q, Zhang W, Wu X, Xu Y, et al. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis. Nephrol Dial Transplant 2012;27:1467-72.